EYE » Topics » Refractive sales rose 1.5% to $118.3 million.

This excerpt taken from the EYE 8-K filed Aug 4, 2008.

Refractive sales rose 1.5% to $118.3 million.

 

 

 

Procedures, implants and related sales were $77.4 million, down slightly from $78.1 million one year ago as U.S. excimer and refractive IOL market weakness was mostly offset by increased global penetration of the company’s IntraLase® technology and international growth of its refractive procedures and implants.

 

   

AMO’s U.S. excimer procedure volumes declined approximately 20% in the second quarter and approximately 6% for the trailing 12 months ended June 27, 2008. For the trailing 12 months ended June 27, 2008, the company’s U.S. custom mix was 67%; the second-quarter custom mix was 68%, compared to 65% in the year-ago quarter.

 

   

AMO’s U.S. femtosecond procedure volumes grew approximately 14% in the second quarter and approximately 25% for the trailing 12 months ended June 27, 2008, on a pro forma basis.

 

   

AMO’s international procedure, implant and related sales hit a new high in the second quarter, at $31.6 million, up 45.1%.

 

 

 

System sales rose 10.1% to $31.3 million, reflecting the continued demand for the company’s iLASIKTM platform worldwide.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki